Letters to the Editor

Posttransplant maintenance with blinatumomab for children, adolescents, and young adults with relapsed and refractory B-cell acute lymphoblastic leukemia: results of phase I in SCT-ALL-BLIN21

Children’s Cancer Center, National Center for Child Health and Development, Tokyo
Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu
Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto
Department of Data Science, The Institute of Statistical Mathematics, Tokyo
Department of Pediatrics, Faculty of Medicine, Kindai University, Sayama
Department of Pediatrics, Kyoto City Hospital, Kyoto
Department of Pediatrics, Tokai University School of Medicine, Isehara
Division of Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama
Department of Pediatrics, Jichi Medical University School of Medicine, Tochigi
Clinical Research Center, NHO Nagoya Medical Center, Nagoya
Clinical Research Center, NHO Nagoya Medical Center, Nagoya
Children’s Cancer Center, National Center for Child Health and Development, Tokyo
Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya
Clinical Research Center, NHO Nagoya Medical Center, Nagoya
Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo
Division of Pediatrics and Perinatology, Tottori University Faculty of Medicine, Yonago
Department of Pediatrics, Shiga University of Medical Science, Otsu
Clinical Research Center, NHO Nagoya Medical Center, Nagoya
Department of Pediatrics, Kagoshima University Hospital, Kagoshima
Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama
Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo
Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto
Collaborative group: The Transplantation and Cellular Therapy Committee of Japanese Children’s Cancer Group ()
Haematologica Early view Jul 10, 2025 https://doi.org/10.3324/haematol.2024.286719